From: Evaluation of temporomandibular joint involvement in juvenile idiopathic arthritis patients
n (%) | |
---|---|
Gender | |
Male | 20 (48.7%) |
Female | 21 (51.2%) |
Age (y) (median, IQR) | 11.55 ± 4.21 (3.6–17.3) |
Age at Diagnosis | |
Early-Onset | 18 (43.9%) |
Late-Onset | 23 (56.01%) |
Disease Duration (y) (median, IQR) | 3.16 ± 1.05 (0.5-7) |
JIA Subtype | |
Oligoarticular Onset | 13 (31.7%) |
Polyarticular Onset | 15 (36.5%) |
Systemic Onset | 5 (12.1%) |
Enthesitis-Related | 4 (9.7%) |
Juvenile Psoriatic Arthritis | 0 (0.0%) |
Number of Involved Joints | |
1–4 | 18 (43.9%) |
≥5 | 23 (56.01%) |
ESR (mm/h) | |
High (> 20) | 22 (52.6%) |
Normal | 19 (47.4%) |
CRP (mg/dl) | |
Positive (> 0.05) | 19 (47.4%) |
Negative | 22 (52.6%) |
Treatment | |
NSAID | 31 (75.6%) |
DMARD | 38 (92.6%) |
Steroids | 30 (73.1%) |
Biological Agents | 7 (17.0%) |
Treatment Response | |
Good | 24 (58.5%) |
Poor | 17 (41.5%) |